FDA Inspection 1123878 — Sterling Pharma Ringaskiddy Limited

Sterling Pharma Ringaskiddy Limited — FEI 3002807776

The FDA completed an inspection of Sterling Pharma Ringaskiddy Limited on September 13, 2019 in Ringaskiddy. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 13, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ringaskiddy (Ireland)

Additional Details

Mutual Recognition Agreement (MRA)